bluebird bio, Inc. (BLUE)
NASDAQ: BLUE · IEX Real-Time Price · USD
0.923
-0.052 (-5.35%)
Jul 2, 2024, 4:00 PM EDT - Market closed
bluebird bio Stock Forecast
BLUE's stock price has decreased by -72.36% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 9 analysts with 12-month price forecasts for bluebird bio stock have an average target of 5.41, with a low estimate of 1.02 and a high estimate of 13. The average target predicts an increase of 486.07% from the current stock price of 0.92.
Analyst Consensus: Hold
* Price targets were last updated on Mar 27, 2024.
Analyst Ratings
The average analyst rating for bluebird bio stock from 10 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Buy | 4 | 4 | 4 | 4 | 4 | 2 |
| Hold | 5 | 5 | 5 | 5 | 5 | 5 |
| Sell | 1 | 1 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Reiterates $8 | Hold | Reiterates | $8 | +766.65% | Mar 27, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +224.99% | Mar 27, 2024 |
| Wedbush | Wedbush | Hold Maintains $3 → $1.68 | Hold | Maintains | $3 → $1.68 | +82.00% | Mar 19, 2024 |
| HSBC | HSBC | Sell Maintains $2.31 → $1.02 | Sell | Maintains | $2.31 → $1.02 | +10.50% | Mar 5, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $12 → $5 | Strong Buy | Maintains | $12 → $5 | +441.65% | Dec 21, 2023 |
Financial Forecast
Revenue This Year
36.01M
from 3.60M
Increased by 901.03%
Revenue Next Year
122.28M
from 36.01M
Increased by 239.60%
EPS This Year
-1.78
from -3.39
EPS Next Year
-1.70
from -1.78
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | 51.5M | 175.9M | 479.9M | 483.3M | 498.4M | 606.4M |
| Avg | 36.0M | 122.3M | 268.2M | 309.2M | 404.9M | 483.1M |
| Low | 28.4M | 76.4M | 183.6M | 122.4M | 341.1M | 384.5M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | 1,330.4% | 388.5% | 292.4% | 80.2% | 61.2% | 49.8% |
| Avg | 901.0% | 239.6% | 119.4% | 15.3% | 30.9% | 19.3% |
| Low | 690.1% | 112.3% | 50.2% | -54.4% | 10.3% | -5.0% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | -1.34 | -1.00 | 0.05 | -0.51 | -0.03 | 0.22 |
| Avg | -1.78 | -1.70 | -0.99 | -0.77 | -0.30 | -0.04 |
| Low | -2.21 | -2.80 | -1.74 | -1.00 | -0.74 | -0.32 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | - | - | - | - |
| Avg | - | - | - | - | - | - |
| Low | - | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.